General information

Contacts

Industries

Jah

VAT liability

Annual reports

✓

Unsubmitted declarations

???

Credit rating

Tax data

✓

Tax debts

Related persons

Holdings in companies

Statistics

Summary of reports

Licenses

Regulations

Real estate

TTJA decisions

Court decisions

Official announcements

Public transactions

.ee domains

✓

Enforcement proceedings

✓

Payment orders

AstraZeneca Eesti OÜ

Legal form:

Private limited company

Registry code:

11733875

VAT no.:

EE101326007

Fiscal-year period:

01.01 - 31.12

Established:

16.10.2009 (16)

Capital:

690 246 EUR

Address:

Valukoja tn 8/1, Lasnamäe linnaosa, Tallinn, Harju maakond, 11415

Status:

Registered

Contacts

Email:

estonia@astrazeneca.com

Phone:

+372 6549600

Website:

www.astrazeneca.ee

Industries

ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES
Office administration and other business support services
Business support service activities n.e.c.
82991 - Other business support service activities n.e.c.

VAT liability

	Start	End
EE101326007	02.11.2009

Annual reports

Aggregate data

	Period	Submitted
2025	01.01.2025 - 31.12.2025	Due date 30.06.2026
2024	01.01.2024 - 31.12.2024	19.06.2025	Valid
2023	01.01.2023 - 31.12.2023	28.06.2024	Valid
2022	01.01.2022 - 31.12.2022	30.05.2023	Valid
2021	01.01.2021 - 31.12.2021	30.06.2022	Valid
2020	01.01.2020 - 31.12.2020	29.06.2021	Valid
2019	01.01.2019 - 31.12.2019	25.06.2020	Valid
2018	01.01.2018 - 31.12.2018	06.06.2019	Valid
2017	01.01.2017 - 31.12.2017	07.06.2018	Valid
2016	01.01.2016 - 31.12.2016	30.05.2017	Valid
2015	01.01.2015 - 31.12.2015	15.06.2016	Valid
2014	01.01.2014 - 31.12.2014	11.06.2015	Valid
2013	01.01.2013 - 31.12.2013	30.06.2014	Valid
2012	01.01.2012 - 31.12.2012	21.06.2013	Valid
2011	01.01.2011 - 31.12.2011	08.06.2012	Valid
2010	16.10.2009 - 31.12.2010	02.08.2011	Valid

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 03.06.2026.

???

Credit rating

Hidden

Credit rating is based on company financial data and payment behavior. detailed analysis available to regia+ users.

020406080100

? Risk factors

? Strengths

View summary

✓

Tax debt

✓

Unsubmitted reports

✓

Unsubmitted declarations

Court decisions

Official announcements

TTJA decisions

Real estate

.ee domains

Licenses

Regulations

Public transactions

Holdings in companies

✓

Enforcement proceedings

✓

Payment orders

Tax data

	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q1	365 564 €	377 589 €	1 692 131 €11.4%	50
Kokku 2026:	365 564 €	377 589 €	1 692 131 €
2025 Q4	438 532 €	437 741 €	1 909 477 €6.0%	44
2025 Q3	427 909 €	446 826 €	1 802 078 €6.7%	58
2025 Q2	698 790 €	732 093 €	1 931 685 €26.5%	45
2025 Q1	351 255 €	364 634 €	1 526 637 €10.5%	49
Kokku 2025:	1 916 486 €	1 981 294 €	7 169 877 €17.0%
2024 Q4	349 002 €	362 932 €	1 380 973 €19.4%	43
2024 Q3	370 033 €	387 680 €	1 713 173 €8.3%	43
2024 Q2	561 906 €	581 548 €	1 581 473 €9.0%	41
2024 Q1	317 962 €	319 665 €	1 451 058 €10.1%	46
Kokku 2024:	1 598 903 €	1 651 825 €	6 126 677 €39.9%
2023 Q4	311 531 €	309 636 €	1 318 384 €0.2%	50
2023 Q3	287 717 €	294 612 €	1 321 340 €0.8%	44
2023 Q2	423 901 €	435 864 €	1 310 461 €205.4%	39
2023 Q1	239 505 €	237 630 €	429 069 €53.2%	47
Kokku 2023:	1 262 653 €	1 277 741 €	4 379 255 €6.1%
2022 Q4	242 779 €	248 166 €	916 951 €21.4%	39
2022 Q3	222 063 €	226 216 €	1 166 222 €17.6%	41
2022 Q2	329 214 €	347 013 €	991 649 €5.7%	39
2022 Q1	213 599 €	221 008 €	1 051 990 €55.0%	39
Kokku 2022:	1 007 655 €	1 042 403 €	4 126 812 €52.3%
2021 Q4	183 244 €	185 650 €	678 904 €4.7%	38
2021 Q3	167 020 €	175 999 €	648 488 €6.7%	32
2021 Q2	235 404 €	249 440 €	695 140 €1.3%	31
2021 Q1	140 442 €	142 441 €	686 529 €6.7%	38
Kokku 2021:	726 110 €	753 530 €	2 709 061 €13.8%
2020 Q4	146 037 €	151 747 €	643 126 €21.4%	27
2020 Q3	161 670 €	170 201 €	529 913 €20.1%	34
2020 Q2	216 343 €	226 732 €	663 226 €21.8%	36
2020 Q1	135 732 €	134 751 €	544 726 €2.4%	33
Kokku 2020:	659 781 €	683 430 €	2 380 991 €3.4%
2019 Q4	135 882 €	136 872 €	532 034 €9.8%	30
2019 Q3	129 553 €	132 237 €	590 014 €12.3%	41
2019 Q2	236 644 €	240 888 €	672 404 €32.5%	25
2019 Q1	140 675 €	143 740 €	507 553 €17.6%	32
Kokku 2019:	642 754 €	653 737 €	2 302 005 €0.8%
2018 Q4	136 775 €	134 997 €	616 035 €11.8%	30
2018 Q3	129 982 €	127 903 €	550 902 €8.2%	29
2018 Q2	195 472 €	197 984 €	599 849 €8.2%	25
2018 Q1	127 639 €	130 831 €	554 238 €18.4%	30
Kokku 2018:	589 868 €	591 715 €	2 321 024 €3.8%
2017 Q4	132 320 €	133 077 €	679 037 €50.6%	28
2017 Q3	149 530 €	155 704 €	450 833 €24.6%	39
2017 Q2	195 726 €	197 489 €	597 786 €17.5%	34
2017 Q1	158 294 €	159 493 €	508 794 €17.1%	39
Kokku 2017:	635 870 €	645 763 €	2 236 450 €4.9%
2016 Q4	139 953 €	145 137 €	434 540 €0.8%	28
2016 Q3	136 316 €	143 935 €	430 944 €44.7%	28
2016 Q2	248 631 €	260 071 €	778 655 €59.4%	28
2016 Q1	155 076 €	163 130 €	488 414 €9.1%	28
Kokku 2016:	679 976 €	712 273 €	2 132 553 €32.6%
2015 Q4	154 458 €	158 375 €	537 504 €51.9%	30
2015 Q3	315 320 €	329 333 €	1 117 709 €17.0%	30
2015 Q2	269 758 €	281 440 €	955 168 €73.0%	30
2015 Q1	160 207 €	162 689 €	552 142 €	30
Kokku 2015:	899 743 €	931 837 €	3 162 523 €

Revenue by industry

	2022	2023	2024
Other business support service activities n.e.c.	3 959 038 €	5 087 993 €	6 287 586 €

Tax debts

No tax debt found

No tax debt as of 03.06.2026

Representatives

Name	Personal ID code	Date of birth	Role	Start	End
Triin Parik	46507XXXXXX	14.07.1965 (60)	Board member	07.02.2025	-
Michal Wronka	81043XXXXXX	-	Board member	16.08.2024	-
Kati Naber	47207XXXXXX	24.07.1972 (53)	Board member	12.10.2018	-
Jesper Bergkvist	-	03.05.1966 (60)	Procurator	23.09.2014	-

7 inactive record hidden, extended access to the information portal is required to view history!

1 - 4 / 4 rows

Shareholders

Name	Personal ID code	Date of birth	Role	Share	%	Type	Start	End
ASTRAZENECA CONTINENT B.V.	NL271XXXXX	-	Shareholder	690 246,00 EUR	100	Sole ownership	16.08.2023	-

5 inactive record hidden, extended access to the information portal is required to view history!

1 - 1 / 1 rows

Other persons

Name	Personal ID code	Date of birth	Role	Start	End
Aktsiaselts PricewaterhouseCoopers	-	-	Audit firm	07.09.2017	-
AstraZeneca Continent B.V.	-	-	Founder	16.10.2009	-

1 - 2 / 2 rows

Ultimate beneficial owners

Name	Personal ID code	Date of birth	Role	Start	End
Michel Demaré	-	31.08.1956 (69)	Member of higher governing body (board or supervisory board)	06.06.2024	-

1 inactive record hidden, extended access to the information portal is required to view history!

1 - 1 / 1 rows

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

2026 Q1

Turnover

Amount

1 692 131 €

Monthly average

564 044 €

Per employee

11 281 €

Equity ratio

81,72%

Labour taxes

Turnover ratio

22,31%

Tax ratio

103,29%

Monthly average

125 863 €

Per employee

2 678 €

State taxes

Monthly average

121 855 €

Turnover ratio

21,60%

Estimated salary

Gross salary

4 751 €

Net salary

3 678 €

Aggregate data

	2024	2023	2022	2021	2020	2019
Current assets	4 906 842 €15.0%	4 265 365 €11.8%	3 813 683 €20.5%	3 163 707 €16.6%	2 713 310 €12.9%	2 403 520 €
Non-current assets	15 422 €15.2%	18 177 €29.1%	25 621 €0.4%	25 519 €21.4%	32 486 €0.6%	32 299 €
Total assets	4 922 264 €14.9%	4 283 542 €11.6%	3 839 304 €20.4%	3 189 226 €16.1%	2 745 796 €12.7%	2 435 819 €
Short-term liabilities	1 597 430 €26.3%	1 264 992 €14.3%	1 107 016 €47.1%	752 326 €34.7%	558 642 €35.7%	411 613 €
Long-term liabilities	-	-	-	-	-	-
Total liabilities	1 597 430 €26.3%	1 264 992 €14.3%	1 107 016 €47.1%	752 326 €34.7%	558 642 €35.7%	411 613 €
Share or stock capital	690 246 €	690 246 €	690 246 €	690 246 €	690 246 €	690 246 €
Retained earnings	2 328 304 €14.0%	2 042 042 €16.9%	1 746 654 €16.7%	1 496 908 €12.2%	1 333 960 €6.8%	1 248 659 €
Net profit	306 284 €7.0%	286 262 €3.1%	295 388 €18.3%	249 746 €53.3%	162 948 €91.0%	85 301 €
Equity	3 324 834 €10.1%	3 018 550 €10.5%	2 732 288 €12.1%	2 436 900 €11.4%	2 187 154 €8.0%	2 024 206 €
Turnover	6 287 586 €23.6%	5 087 993 €28.5%	3 959 038 €30.0%	3 045 823 €22.1%	2 494 087 €6.8%	2 335 467 €
Profit margin	4.87%13.4%	5.63%24.6%	7.46%9.0%	8.20%25.5%	6.53%78.9%	3.65%

Financial ratios

	2024	2023	2022	2021	2020
Profit and cash flow
EBITDA	HRK PXA	TKD WGI	DDL MUD	256 717	169 467
Liquidity
Current ratio	X.O	D.G	K.K	4.2	4.9
Quick ratio	J.Y	F.J	F.J	4.2	4.9
Cash ratio	Q.N	X.J	A.N	3.3	4.2
Efficiency
Days sales outstanding (dso)	GA.S	VQ.N	ZS.G	63.1	45.6
Asset turnover	O.R	L.N	K.V	1.0	1.0
Structure
Debt ratio	P.G	U.X	K.R	0.2	0.2
Profitability
Operating margin	B.L%	L.P%	Q.Y%	8.2%	6.5%
Net profit margin	P.S%	Z.V%	O.M%	8.2%	6.5%
Return on assets (roa)	A.H%	O.G%	C.B%	8.4%	6.3%
Return on equity (roe)	S.X%	I.G%	BR.F%	10.2%	7.5%

To view all financial ratios, you need to subscribe to extended access to the info portal!

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations

Regulation no.	Date	Type	Status
Ä 10135171 / 19	07.02.2025	Entry - Amendment entry	Entered into force (07.02.2025)
Ä 10135171 / 18	16.08.2024	Entry - Amendment entry	Entered into force (16.08.2024)
Ä 10135171 / 17	16.12.2021	Entry - Amendment entry	Entered into force (16.12.2021)
Ä 10135171 / 16	30.11.2018	Entry - Amendment entry	Entered into force (30.11.2018)
Ä 10135171 / 15	12.10.2018	Entry - Amendment entry	Entered into force (12.10.2018)

1 - 5 / 23 rows

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Official announcements

No official announcements found

Company has no issued official announcements

Public transactions

No public transactions found

Company has no public transactions

.ee domains

Domain	Status	Registered	Expires	End
rinnavähk.ee	Active	16.08.2011	17.08.2026	-
turbuhaler.ee	Active	08.07.2010	09.07.2026	-
astma.ee	Active	04.07.2010	20.08.2026	-
rinnavahk.ee	Active	04.07.2010	20.08.2026	-
astrazeneca.ee	Active	04.07.2010	20.08.2026	-

1 - 5 / 5 rows

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders